Stockreport

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced [Read more]